Literature DB >> 28331758

Secretory Carcinoma of the Breast.

Fatma Aktepe1, Dauren Sarsenov1, Vahit Özmen1.   

Abstract

Secretory carcinoma is a very rare subtype of breast carcinoma. These tumors are generally associated with a favorable prognosis, although having triple-negative phenotype (estrogen receptor (ER), progesterone receptor (PR) negative and c-erbB2 (HER2) negative). In this presentation, a rare secretory carcinoma of the breast in a woman aged 24 years is discussed and the literature is reviewed.

Entities:  

Keywords:  Secretory carcinoma; breast; immunohistochemistry

Year:  2016        PMID： 28331758      PMCID： PMC5351444          DOI： 10.5152/bs.2016.3249

Source DB:  PubMed          Journal:  J Breast Health        ISSN： 1306-0945


  7 in total

1.  Secretory carcinoma of breast in an elderly female.

Authors:  R Sharma; S Singh; T S Jaswal
Journal:  Indian J Pathol Microbiol       Date:  2001-10       Impact factor: 0.740

2.  A rare case of multicentric secretory carcinoma of breast in an adult female with review of literature.

Authors:  Maithili Mandar Kulkarni; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Ashish N Dhande
Journal:  Indian J Pathol Microbiol       Date:  2016 Apr-Jun       Impact factor: 0.740

3.  Breast carcinoma in children.

Authors:  R W McDivitt; F W Stewart
Journal:  JAMA       Date:  1966-01-31       Impact factor: 56.272

Review 4.  Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature.

Authors:  G Richard; J C Hawk; A S Baker; R M Austin
Journal:  J Surg Oncol       Date:  1990-08       Impact factor: 3.454

Review 5.  Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.

Authors:  Dali Li; Xiuying Xiao; Wentao Yang; Ruohong Shui; Xiaoyu Tu; Hongfen Lu; Daren Shi
Journal:  Mod Pathol       Date:  2011-12-09       Impact factor: 7.842

6.  Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature.

Authors:  C Arce; D Cortes-Padilla; D G Huntsman; M A Miller; A Dueñnas-Gonzalez; A Alvarado; V Pérez; D Gallardo-Rincón; F Lara-Medina
Journal:  World J Surg Oncol       Date:  2005-06-17       Impact factor: 2.754

7.  What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).

Authors:  A Drilon; G Li; S Dogan; M Gounder; R Shen; M Arcila; L Wang; D M Hyman; J Hechtman; G Wei; N R Cam; J Christiansen; D Luo; E C Maneval; T Bauer; M Patel; S V Liu; S H I Ou; A Farago; A Shaw; R F Shoemaker; J Lim; Z Hornby; P Multani; M Ladanyi; M Berger; N Katabi; R Ghossein; A L Ho
Journal:  Ann Oncol       Date:  2016-02-15       Impact factor: 32.976
  7 in total
  4 in total

Review 1.  Triple-negative breast cancer: A run-through of features, classification and current therapies.

Authors:  Meghana Manjunath; Bibha Choudhary
Journal:  Oncol Lett       Date:  2021-05-05       Impact factor: 2.967

Review 2.  Triple negative breast cancer: special histological types and emerging therapeutic methods.

Authors:  Lu Cao; Yun Niu
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

3.  Secretory Carcinoma of the Breast: A Case Report and Literature Review.

Authors:  I-Kai Wu; Yi-Chen Lai; Hong-Jen Chiou; Chih-Yi Hsu
Journal:  J Med Ultrasound       Date:  2020-05-18

4.  Secretory carcinoma of the canine mammary gland with nodal and bone metastases: Case report.

Authors:  Halana do Carmo Silva; Marina Possa Dos Reys; Geovanni Dantas Cassali; Fernanda Rezende Souza; Rodrigo Dos Santos Horta; Bruna Voltolin de Sena; Adriano Lima Stelzer Bindaco; Ana Carolina Jesus de Pinto; Tayse Domingues de Souza; Mayra Cunha Flecher
Journal:  Open Vet J       Date:  2022-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.